Evidence map›Paper›PMID 22369086›Full record

ArticleBMC genomics2011

Genetic copy number variants in myocardial infarction patients with hyperlipidemia.

Wei-Chung Shia, Tien-Hsiung Ku, Yu-Ming Tsao, Chien-Hsun Hsia, Yung-Ming Chang, Ching-Hui Huang, Yeh-Ching Chung, Shih-Lan Hsu, Kae-Woei Liang, Fang-Rong Hsu

Open access · goldAbstract read
In one paragraph

Article in BMC genomics, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. BIOFILTER AS A FUNCTIONAL ANNOTATION PIPELINE FOR COMMON AND RARE COPY NUMBER BURDEN.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2016
    Article
  14. Gene Expression Signatures and the Spectrum of Coronary Artery Disease.Journal of cardiovascular translational research · 2015
    Review
  15. Article
  16. Article
  17. Article
  18. Cardiometabolic effects of adiponectin.Best practice & research. Clinical endocrinology & metabolism · 2014
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Wei-Chung ShiaDepartment of Information Engineering and Computer Science, Feng Chia University, Taichung City, Taiwan.
Tien-Hsiung Ku
Yu-Ming Tsao
Chien-Hsun Hsia
Yung-Ming Chang
Ching-Hui Huang
Yeh-Ching Chung
Shih-Lan Hsu
Kae-Woei Liang
Fang-Rong Hsu
Changhua Christian Hospital · TWFeng Chia University · TWTaichung Veterans General Hospital · TWNational Tsing Hua University · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular disease is the chief cause of death in Taiwan and many countries, of which myocardial infarction (MI) is the most serious condition. Hyperlipidemia appears to be a significant cause of myocardial infarction, because it causes atherosclerosis directly. In recent years, copy number variation (CNV) has been analyzed in genomewide association studies of complex diseases. In this study, CNV was analyzed in blood samples and SNP arrays from 31 myocardial infarction patients with hyperlipidemia.

resultsWe identified seven CNV regions that were associated significantly with hyperlipidemia and myocardial infarction in our patients through multistage analysis (P<0.001), at 1p21.3, 1q31.2 (CDC73), 1q42.2 (DISC1), 3p21.31 (CDCP1), 10q11.21 (RET) 12p12.3 (PIK3C2G) and 16q23.3 (CDH13), respectively. In particular, the CNV region at 10q11.21 was examined by quantitative real-time PCR, the results of which were consistent with microarray findings.

conclusionsOur preliminary results constitute an alternative method of evaluating the relationship between CNV regions and cardiovascular disease. These susceptibility CNV regions may be used as biomarkers for early-stage diagnosis of hyperlipidemia and myocardial infarction, rendering them valuable for further research and discussion.

Indexed as

DNA Copy Number VariationsAdultAgedCholesterolFemaleGenome-Wide Association StudyHumansHyperlipidemiasLipoproteins, LDLMaleMiddle AgedMyocardial InfarctionPolymorphism, Single NucleotideYoung AdultCholesterolLipoproteins, LDL

Identifiers

PMID22369086
PMCPMC3333183
OpenAlexW2013998906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.